UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
February 17, 2005
Date of Report (Date of earliest event reported)
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)
Commission File Number 0-7154
PENNSYLVANIA | No. 23-0993790 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
One Quaker Park
901 Hector Street
Conshohocken, Pennsylvania 19428
(Address of principal executive offices)
(Zip Code)
(610) 832-4000
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
INFORMATION TO BE INCLUDED IN THE REPORT
Item 2.02. Results of Operations and Financial Condition.
On February 17, 2005, Quaker Chemical Corporation announced its results of operations for the fourth quarter and full year ended December 31, 2004 in a press release, the text of which is included as Exhibit 99.1 hereto.
Item 8.01. Other Events
On February 17, 2005, Quaker Chemical Corporation announced that Quaker Park Associates, a real estate development joint venture of which Quaker owns 50%, has sold its real estate assets. Quakers share of the proceeds from this real estate transaction, after payment of partnership obligations, is estimated at $4.2 million.
Item 9.01. Financial Statements and Exhibits.
The following exhibit is included as part of this report:
Exhibit No. |
||
99.1 | Press Release of Quaker Chemical Corporation dated February 17, 2005. |
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUAKER CHEMICAL CORPORATION | ||||
Registrant | ||||
Date: February 17, 2005 |
By: | /s/ NEAL E. MURPHY | ||
Neal E. Murphy Vice President and Chief Financial Officer |
-3-
EXHIBIT 99.1
For Release: |
NEWS |
Contact: | ||
Immediate |
Neal E. Murphy | |||
Vice President and | ||||
Chief Financial Officer | ||||
610/832-4189 |
QUAKER CHEMICAL ANNOUNCES FOURTH QUARTER AND FULL YEAR 2004 RESULTS
February 17, 2005
CONSHOHOCKEN, PA - Quaker Chemical Corporation (NYSE:KWR) today announced record quarterly and annual sales of $104.2 million and $400.7 million, respectively, and diluted earnings per share of $0.17 for the fourth quarter and $0.90 for the full year, inclusive of a $0.5 million pre-tax charge for restructuring and other related activities in the fourth quarter.
Fourth Quarter Summary
Net sales for the fourth quarter of 2004 were $104.2 million, up 11% from $93.7 million for the fourth quarter of 2003. Foreign exchange rate translation favorably impacted net sales by $3.4 million or 3%, with the remaining net sales increase of approximately 8% attributable to volume growth and higher prices. Sales in the North American, South American and Asia/Pacific regions increased, tempered by lower sales in Europe, while price increases implemented across all regions helped to partially offset higher raw material costs.
Net income for the fourth quarter decreased to $1.7 million versus $4.1 million for the fourth quarter of 2003. Significantly higher raw material costs and higher selling, general and administrative costs were largely responsible for the shortfall in earnings compared to the prior year period. Fourth quarter net income also included a pre-tax restructuring and related activity charge of $0.5 million. Compared to the third quarter of 2004, the Companys net income increased approximately 44% despite this charge.
Gross margin as a percentage of sales declined from 35.5% for the fourth quarter of 2003 to 32.8% for the fourth quarter of 2004. The continued high prices for the Companys raw materials, particularly crude oil, as well as unfavorable product and regional sales mix, were responsible for the decline in gross margin percentage. However, the gross margin as a percentage of sales recovered one full percentage point from the 31.8% reported for the third quarter of 2004, as the Company began to benefit from recent pricing actions.
Selling, general and administrative expenses for the quarter increased $3.6 million compared to the fourth quarter of 2003. Foreign exchange rate translation and the Companys 2003 acquisitions accounted for approximately one-third of the increase. The majority of the remaining increase was due to costs associated with key strategic initiatives, as well as a range of administrative costs such as Sarbanes-Oxley compliance. During the fourth quarter of 2004, the Company began efforts to realign the organization and reduce costs by announcing the consolidation of its administrative facilities in Hong Kong with its Shanghai headquarters, resulting in a $0.5 million pre-tax charge for restructuring and related activities.
The increase in other income for the fourth quarter of 2004 primarily reflects a gain on the sale of real estate by the Companys majority owned Australian subsidiary, which also resulted in an increase in minority interest expense.
Ronald J. Naples, Chairman and Chief Executive Officer commented, While earnings for the quarter are below historical levels due primarily to the dramatic increase in raw material costs, our fourth quarter represents a positive first step on the road to recovery after a very disappointing third quarter. We continue to generate strong revenue growth, and the pricing actions we have taken in the latter part of 2004 are starting to move our gross margins in the right direction.
- more -
Full Year Summary
Net sales for 2004 increased to $400.7 million, up 18% from $340.2 million for 2003. Foreign exchange rate translation, the full year impact of the Companys 2003 acquisitions, and the Companys new Chemical Management Services (CMS) contracts favorably impacted net sales by approximately $14.7 million, $16.2 million and $17.2 million, respectively. The remaining net sales increase of approximately 3.6% was attributable to growth in the Asia/Pacific and North and South American regions partially offset by lower sales in Europe.
Net income was $9.0 million in 2004 versus $14.8 million in 2003 due to significantly higher raw material costs, and higher selling, general and administrative costs. Earnings per diluted share decreased from $1.52 to $0.90, inclusive of a $0.5 million pre-tax charge for restructuring and other related activities.
Gross margin as a percentage of sales declined from 35.7% for 2003 to 32.7% for 2004 due to a number of factors. The Companys new CMS contracts have caused different relationships between margins and revenue than in the past. At the majority of CMS sites, the Company effectively acts as an agent and records revenue and costs from these sales on a net sales or pass-through basis. The new CMS contracts have a different structure, which results in the Company recognizing in reported revenue the gross revenue received from the CMS site customer, and in cost of goods sold the third party product purchases. The negative impact to gross margin percentage for 2004 versus the prior year related to the new CMS contracts is approximately 1.3 percentage points. The remaining decline in gross margin as a percentage of sales is primarily due to increased raw material costs. Unfavorable product and regional mix also contributed to the decline in margin percentage.
Selling, general and administrative expenses for 2004 increased $16.3 million from 2003. Foreign exchange rate translation and the Companys 2003 acquisitions accounted for approximately 40% of the increase. The majority of the remaining increase was due to costs associated with strategic initiatives, as well as a range of administrative costs such as Sarbanes-Oxley compliance, pension, incentive compensation, and higher sales commissions.
Balance Sheet and Cash Flow Items
The Companys net debt has increased since 2003 primarily to fund the working capital needs associated with its growth initiatives. The Companys net debt-to-total capital was 28% at the end of 2004 compared to 25% at the end of 2003. In the fourth quarter of 2004, the Company took action in the U.S. and Europe to increase its credit facilities by $25.0 million. Therefore, the Companys credit lines now total $95.0 million, $40.0 million committed and $55.0 million uncommitted. At December 31, 2004, the Company had approximately $57.0 million outstanding on its credit lines.
2005 Outlook
Mr. Naples stated, We expect earnings to improve after a disappointing 2004. Our plans call for high single-digit revenue growth, and we expect margins to improve over 2004, assuming raw material costs stabilize. We would certainly benefit from downward movement in the cost of key raw materials but are not seeing indications of such movement at this time. In the fourth quarter, we began to take steps that reduce costs, but still allow us to maintain the high customer service, global approach to our customers that sets us apart from our competitors. Further cost reduction steps are being taken in the first quarter, while we redirect resources to business building initiatives such as market development in a growing Asian market, continued market penetration and product conversions in chemical management services, and development of new complementary businesses.
Mr. Naples continued, We remain convinced that we are on the right strategic track of selling value rather than simply fluids, operating as a globally integrated whole, and harnessing our global knowledge. Our commitment to these imperatives has enabled us to maintain our strong market position in a difficult operating environment and will serve us well given the increasing global nature of our customer base.
Mr. Naples also added, We anticipate that our strong financial position and cash flow generation will enable continued pursuit of acquisitions, including the possible acquisition of JV partner interests. The roughly $4.2 million cash proceeds related to todays earlier announced sale of the assets of our real estate joint venture is a plus for us this year. We also expect to continue to maintain our record of annual dividend increases.
- more -
Quaker Chemical Corporation, headquartered in Conshohocken, Pennsylvania, is a worldwide developer, producer, and marketer of custom-formulated chemical specialty products and a provider of chemical management services for manufacturers around the globe, primarily in the steel and automotive industries.
This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Companys demand is largely derived from the demand for its customers products, which subjects the Company to downturns in a customers business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, and future terrorist attacks such as those that occurred on September 11, 2001. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
As previously announced, Quaker Chemicals investor conference to discuss fourth quarter results is scheduled for February 18, 2005 at 2:30 p.m. (ET). Access the conference by calling 877-269-7756 (toll free) or visit Quakers Web site at http://www.quakerchem.com for a live webcast.
- more -
Quaker Chemical Corporation
Condensed Consolidated Statement of Income
(Dollars in thousands, except per share data and share amounts)
(Unaudited) |
||||||||||||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net sales |
$ | 104,214 | $ | 93,689 | $ | 400,695 | $ | 340,192 | ||||||||
Cost of goods sold |
70,027 | 60,413 | 269,818 | 218,818 | ||||||||||||
Gross margin |
34,187 | 33,276 | 130,877 | 121,374 | ||||||||||||
% |
32.8 | % | 35.5 | % | 32.7 | % | 35.7 | % | ||||||||
Selling, general and administrative |
30,480 | 26,835 | 113,536 | 97,202 | ||||||||||||
Restructuring and related activities, net |
450 | 57 | 450 | 57 | ||||||||||||
Operating income |
3,257 | 6,384 | 16,891 | 24,115 | ||||||||||||
% |
3.1 | % | 6.8 | % | 4.2 | % | 7.1 | % | ||||||||
Other income, net |
629 | (66 | ) | 1,818 | 764 | |||||||||||
Interest expense, net |
(286 | ) | (147 | ) | (1,252 | ) | (761 | ) | ||||||||
Income before taxes |
3,600 | 6,171 | 17,457 | 24,118 | ||||||||||||
Taxes on income |
1,134 | 2,104 | 5,499 | 7,488 | ||||||||||||
2,466 | 4,067 | 11,958 | 16,630 | |||||||||||||
Equity in net income of associated companies |
291 | 774 | 890 | 1,244 | ||||||||||||
Minority interest in net income of subsidiaries |
(1,093 | ) | (726 | ) | (3,874 | ) | (3,041 | ) | ||||||||
Net income |
$ | 1,664 | $ | 4,115 | $ | 8,974 | $ | 14,833 | ||||||||
% |
1.6 | % | 4.4 | % | 2.2 | % | 4.4 | % | ||||||||
Per share data: |
||||||||||||||||
Net income - basic |
$ | 0.17 | $ | 0.43 | $ | 0.93 | $ | 1.58 | ||||||||
Net income - diluted |
$ | 0.17 | $ | 0.41 | $ | 0.90 | $ | 1.52 | ||||||||
Shares Outstanding: |
||||||||||||||||
Basic |
9,627,360 | 9,516,698 | 9,606,074 | 9,381,267 | ||||||||||||
Diluted |
9,929,474 | 9,954,500 | 9,969,044 | 9,761,261 |
- more -
Quaker Chemical Corporation
Condensed Consolidated Balance Sheet
(Dollars in thousands, except par value and share amounts)
(Unaudited) |
||||||||
December 31, 2004 |
December 31, 2003 |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 29,078 | $ | 21,915 | ||||
Accounts receivable, net |
87,527 | 78,121 | ||||||
Inventories, net |
41,298 | 32,211 | ||||||
Deferred income taxes |
4,373 | 4,278 | ||||||
Prepaid expenses and other current assets |
8,911 | 6,417 | ||||||
Total current assets |
171,187 | 142,942 | ||||||
Property, plant, and equipment, net |
62,888 | 62,391 | ||||||
Goodwill |
34,853 | 33,301 | ||||||
Other intangible assets, net |
8,574 | 9,616 | ||||||
Investments in associated companies |
6,718 | 6,005 | ||||||
Deferred income taxes |
18,825 | 15,548 | ||||||
Other assets |
21,848 | 19,664 | ||||||
Total assets |
$ | 324,893 | $ | 289,467 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities |
||||||||
Short-term borrowings and current portion of long-term debt |
$ | 60,695 | $ | 42,992 | ||||
Accounts payable |
40,183 | 39,240 | ||||||
Dividends payable |
2,079 | 2,019 | ||||||
Accrued compensation |
8,692 | 6,816 | ||||||
Other current liabilities |
13,969 | 14,738 | ||||||
Total current liabilities |
125,618 | 105,805 | ||||||
Long-term debt |
14,848 | 15,827 | ||||||
Deferred income taxes |
5,588 | 4,808 | ||||||
Accrued pension and postretirement benefits |
36,456 | 34,165 | ||||||
Other non-current liabilities |
7,372 | 6,802 | ||||||
Total liabilities |
189,882 | 167,407 | ||||||
Minority interest in equity of subsidiaries |
12,424 | 9,708 | ||||||
Shareholders equity |
||||||||
Common stock, $1 par value; authorized 30,000,000 shares; issued 9,668,751 shares |
9,669 | 9,664 | ||||||
Capital in excess of par value |
2,632 | 2,181 | ||||||
Retained earnings |
117,981 | 117,308 | ||||||
Unearned compensation |
(355 | ) | (621 | ) | ||||
Accumulated other comprehensive loss |
(7,340 | ) | (15,406 | ) | ||||
122,587 | 113,126 | |||||||
Treasury stock, shares held at cost; 2004 - 0, 2003 - 54,178 |
| (774 | ) | |||||
Total shareholders equity |
122,587 | 112,352 | ||||||
Total liabilities and shareholders equity |
$ | 324,893 | $ | 289,467 | ||||
- more -
Quaker Chemical Corporation
Condensed Consolidated Statement of Cash Flows
For the twelve months ended December 31,
(Dollars in thousands)
(Unaudited) |
||||||||
2004 |
2003 |
|||||||
Cash flows from operating activities |
||||||||
Net income |
$ | 8,974 | $ | 14,833 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Depreciation |
8,610 | 6,677 | ||||||
Amortization |
1,157 | 960 | ||||||
Equity in net income of associated companies |
(890 | ) | (844 | ) | ||||
Minority interest in earnings of subsidiaries |
3,874 | 3,041 | ||||||
Deferred income taxes |
(1,872 | ) | 402 | |||||
Deferred compensation and other, net |
(39 | ) | (418 | ) | ||||
Restructuring and related activities |
450 | 57 | ||||||
Gain on sale of property, plant, and equipment |
(509 | ) | | |||||
Pension and other postretirement benefits |
(172 | ) | 428 | |||||
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions: |
||||||||
Accounts receivable |
(6,361 | ) | (14,604 | ) | ||||
Inventories |
(7,559 | ) | (4,692 | ) | ||||
Prepaid expenses and other current assets |
(281 | ) | (648 | ) | ||||
Accounts payable and accrued liabilities |
129 | 478 | ||||||
Change in restructuring liabilities |
(558 | ) | (1,083 | ) | ||||
Estimated taxes on income |
(1,596 | ) | 3,790 | |||||
Net cash provided by operating activities |
$ | 3,357 | $ | 8,377 | ||||
Cash flows from investing activities |
||||||||
Capital expenditures |
(8,643 | ) | (12,608 | ) | ||||
Dividends and distributions from associated companies |
288 | 4,080 | ||||||
Payments related to acquisitions |
| (15,983 | ) | |||||
Proceeds from disposition of assets |
1,880 | 232 | ||||||
Other, net |
(75 | ) | (87 | ) | ||||
Net cash (used in) investing activities |
(6,550 | ) | (24,366 | ) | ||||
Cash flows from financing activities |
||||||||
Net increase in short-term borrowings |
17,683 | 30,581 | ||||||
Proceeds from long-term debt |
2,564 | | ||||||
Repayments of long-term debt |
(3,679 | ) | (2,570 | ) | ||||
Dividends paid |
(8,241 | ) | (7,916 | ) | ||||
Stock options exercised, other |
1,009 | 4,328 | ||||||
Distributions to minority shareholders |
(1,956 | ) | (2,391 | ) | ||||
Net cash provided by financing activities |
7,380 | 22,032 | ||||||
Effect of exchange rate changes on cash |
2,976 | 2,015 | ||||||
Net increase in cash and cash equivalents |
7,163 | 8,058 | ||||||
Cash and cash equivalents at the beginning of the period |
21,915 | 13,857 | ||||||
Cash and cash equivalents at the end of the period |
$ | 29,078 | $ | 21,915 | ||||